Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial
在接受或未接受紧急糖蛋白IIb/IIIa抑制剂(GPI)治疗的患者中,比伐卢定与肝素的疗效比较:BRIGHT-4试验的预设亚组分析
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-024-03579-6
Liao, Jia; Qiu, Miaohan; Feng, Xiaojian; Chen, Kui; Zhang, Dingbao; Zou, Yuncheng; Zheng, Xiaohui; Zhao, Gang; Tian, Nailiang; Zheng, Zeqi; Peng, Xiaoping; Yang, Qing; Liang, Zhenyang; Li, Yi; Han, Yaling; Stone, Gregg W